JP2015501791A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015501791A5 JP2015501791A5 JP2014540950A JP2014540950A JP2015501791A5 JP 2015501791 A5 JP2015501791 A5 JP 2015501791A5 JP 2014540950 A JP2014540950 A JP 2014540950A JP 2014540950 A JP2014540950 A JP 2014540950A JP 2015501791 A5 JP2015501791 A5 JP 2015501791A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxyethyl
- gataparsen
- m5ru
- manufactured
- thoxyethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2011-0117082 | 2011-11-10 | ||
| KR1020110117082A KR101383324B1 (ko) | 2011-11-10 | 2011-11-10 | 신규한 유전자 전달용 조성물 |
| PCT/KR2012/009443 WO2013070010A1 (en) | 2011-11-10 | 2012-11-09 | Novel composition for gene delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015501791A JP2015501791A (ja) | 2015-01-19 |
| JP2015501791A5 true JP2015501791A5 (enExample) | 2015-05-21 |
| JP5923177B2 JP5923177B2 (ja) | 2016-05-24 |
Family
ID=48290305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540950A Active JP5923177B2 (ja) | 2011-11-10 | 2012-11-09 | 新規な遺伝子伝達用組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9173853B2 (enExample) |
| EP (1) | EP2776056B1 (enExample) |
| JP (1) | JP5923177B2 (enExample) |
| KR (1) | KR101383324B1 (enExample) |
| ES (1) | ES2621403T3 (enExample) |
| WO (1) | WO2013070010A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101494594B1 (ko) | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
| KR101586791B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
| CN105143193B (zh) | 2013-01-31 | 2017-12-15 | 株式会社钟根堂 | 作为cetp抑制剂的联芳基或杂环联芳基取代的环己烯衍生化合物 |
| KR101601035B1 (ko) | 2013-02-28 | 2016-03-08 | 주식회사 종근당 | 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물 |
| CL2014003514A1 (es) * | 2014-12-23 | 2015-05-08 | Univ De Concepción | Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central. |
| KR101916193B1 (ko) | 2016-08-25 | 2018-11-07 | 주식회사 파마리서치프로덕트 | 핵산 및 키토산을 포함하는 관절강 주사용 조성물 |
| ES2994451T3 (en) | 2017-04-20 | 2025-01-24 | Atyr Pharma Inc | Compositions for treating lung inflammation |
| CR20200653A (es) | 2018-07-03 | 2021-02-11 | Gilead Sciences Inc | Anticuerpos que se dirigen al gp120 de vih y métodos de uso |
| CA3106563A1 (en) | 2018-07-26 | 2020-01-30 | Atyr Pharma, Inc. | Compositions and methods for treating nrp2-associated diseases |
| MX2021015452A (es) | 2019-06-25 | 2022-02-11 | Gilead Sciences Inc | Proteinas de fusion flt3l-fc y metodos de uso. |
| CA3145791A1 (en) | 2019-07-16 | 2021-01-21 | Gilead Sciences, Inc. | Hiv vaccines and methods of making and using |
| KR20220074917A (ko) | 2019-09-30 | 2022-06-03 | 길리애드 사이언시즈, 인코포레이티드 | Hbv 백신 및 hbv를 치료하는 방법 |
| CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
| TW202406932A (zh) | 2020-10-22 | 2024-02-16 | 美商基利科學股份有限公司 | 介白素2-Fc融合蛋白及使用方法 |
| JP2025523043A (ja) | 2022-07-12 | 2025-07-17 | ギリアード サイエンシーズ， インコーポレイテッド | Ｈｉｖ免疫原性ポリペプチド及びワクチン、並びにその使用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008202A (en) | 1995-01-23 | 1999-12-28 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| NZ505876A (en) * | 1998-01-16 | 2002-12-20 | Univ Johns Hopkins | Solid nanosphere composition and delivery of a coacervate polymeric cation (gelatine or chitosan) and a polyanion (nucleic acids) |
| US20030134810A1 (en) * | 2001-10-09 | 2003-07-17 | Chris Springate | Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents |
| WO2004074314A2 (en) * | 2003-02-14 | 2004-09-02 | University Of South Florida | Chistosan-microparticles for ifn gene delivery |
| KR100882611B1 (ko) * | 2006-11-14 | 2009-02-12 | 주식회사 키토라이프 | 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법 |
| KR100825519B1 (ko) * | 2007-01-05 | 2008-04-25 | 주식회사 바이오폴리메드 | 키토산 기재 고분자 접합체 및 그 제조방법 |
| WO2009120247A2 (en) | 2007-12-27 | 2009-10-01 | The Ohio State University Research Foundation | Lipid nanoparticle compositions and methods of making and using the same |
| KR101494594B1 (ko) | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
-
2011
- 2011-11-10 KR KR1020110117082A patent/KR101383324B1/ko active Active
-
2012
- 2012-11-09 EP EP12847217.2A patent/EP2776056B1/en active Active
- 2012-11-09 WO PCT/KR2012/009443 patent/WO2013070010A1/en not_active Ceased
- 2012-11-09 US US14/357,375 patent/US9173853B2/en active Active
- 2012-11-09 JP JP2014540950A patent/JP5923177B2/ja active Active
- 2012-11-09 ES ES12847217.2T patent/ES2621403T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015501791A5 (enExample) | ||
| Xiong et al. | Amphiphilic block co-polymers: preparation and application in nanodrug and gene delivery | |
| EA201170039A1 (ru) | Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения | |
| JP2013507423A5 (enExample) | ||
| EA201290482A1 (ru) | Стабильные составы для лиофилизации терапевтических частиц | |
| WO2014004436A3 (en) | Crystalline anti-human il-23 antibodies | |
| RU2013141449A (ru) | Модуляция роста бифидобактерий в сочетании с олигосахаридами, находящимися в материнском молоке | |
| BR112014014599A8 (pt) | polímeros de alfa-aminoamidina e uso dos mesmos | |
| EA201591027A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
| PH12014502524A1 (en) | Carboxylic acid compounds | |
| SG10201804024VA (en) | Formulations of azaindole compounds | |
| HK1214499A1 (zh) | 穩定的低粘度抗體配製品 | |
| JP2011105738A5 (enExample) | ||
| MD20140073A2 (en) | New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them | |
| JP2015007131A5 (enExample) | ||
| MY180145A (en) | Cenicriviroc compositions and methods of making and using the same | |
| MY178888A (en) | Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same | |
| JP2014097964A5 (enExample) | ||
| CA2920410C (en) | Thienopiperidine derivative and use thereof | |
| JP2015509075A5 (enExample) | ||
| JP2013518036A5 (enExample) | ||
| JP2013535445A5 (enExample) | ||
| BR112014017163A2 (pt) | composição de colírio | |
| JP2014500250A5 (enExample) | ||
| RU2015110285A (ru) | Материалы носителя катализатора, катализаторы, способы их получения и применения |